5

Exhibit 27 for Bristol-Myers Squibb for nine months ended September 30, 2000 1,000,000 9-MOS Jan-01-2000 Dec-31-2000 Sep-30-2000 2,760 202 3,782 0 1,852 9,671 7,798 3,367 17,467 5,559 1,323 0 0 220 8,936 17,467 13,432 13,432 3,471 3,471 2,614 0 76 4,032 1,005 3,027 521 0 0 3,548 1.8 1.77 Receivables are reported net of allowances for doubtful accounts Items reported as "zero" are not applicable or immaterial to the consolidated financial position of the Company